Chest Pain Troponin Interpretation

For acute chest pain or an anginal equivalent concerning for ACS, obtain a 12-lead ECG within 10 minutes of ED arrival and draw troponin without delay.PubMed+1PubMedTriaging Down the 2021 Chest Pain GuidelinesPubMedImplementation of High-Sensitivity Troponin for Early Rule-Out of Acute Myocardial Infarction in Emergency Department - PMC STEMI and very-high-risk NSTE-ACS are ECG- and clinical-emergency diagnoses; serial hs-cTn testing is important for confirmation and risk assessment but must not delay reperfusion-oriented evaluation when the ECG is diagnostic.PubMedPubMedAcute ST-Segment Elevation Myocardial Infarction (STEMI) - NCBI

Use hs-cTnI or hs-cTnT when available. The 2021 multisociety chest pain guideline identifies hs-cTn as the preferred biomarker, and the 2022 ACC pathway recommends U.S. centers transition to hs-cTn assays for acute chest-pain evaluation.ScienceDirect+1ScienceDirectImplementation of High-Sensitivity Cardiac Troponin Assays in the ...PubMed2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department Do not apply hs-cTn accelerated pathways to older-generation, less-sensitive troponin assays.PubMedPubMed2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department

Repeat the ECG when symptoms recur, evolve, or remain concerning despite an initially nondiagnostic tracing; interpretation of ischemia requires integration of symptom timing, ECG findings, and serial hs-cTn concentrations.PubMedPubMedChest Pain: Evaluation and Exclusion of Myocardial Infarction and ... A normal ECG lowers but does not independently eliminate the possibility of ACS, particularly early after symptom onset or in patients with ongoing high-risk clinical features.PubMed+1PubMedTriaging Down the 2021 Chest Pain GuidelinesPubMed2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department

Classify any hs-cTn concentration above the assay-specific 99th-percentile URL as myocardial injury.PubMed+1PubMedHigh-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. - AbstractPubMedAcute ST-Segment Elevation Myocardial Infarction (STEMI) - NCBI Diagnose acute MI only when abnormal hs-cTn shows a rise and/or fall and the patient has evidence of acute myocardial ischemia from the clinical presentation, ECG, imaging, or other ischemic evidence.PubMedPubMedAcute ST-Segment Elevation Myocardial Infarction (STEMI) - NCBI Thus, a single value above the URL establishes injury but cannot by itself distinguish type 1 MI from nonischemic injury or chronic elevation.PubMedPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

A dynamic concentration pattern supports acute injury. Interpret the delta using the locally validated assay-specific pathway, including its designated sampling interval and absolute or relative change criteria; hs-cTn assays differ in analytical characteristics, limits of detection, and 99th-percentile URLs, so values and deltas cannot be transferred between assays.PubMed+2PubMedHigh-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. - AbstractPubMedUse of high‐sensitivity cardiac troponin in the emergency department: A policy resource and education paper (PREP) from the American College of Emergency PhysiciansPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

A persistently elevated value with little serial change should prompt assessment for chronic myocardial injury or an alternate acute cause rather than automatic labeling as NSTEMI. In contrast, a rise or fall establishes acute injury, after which ischemic symptoms, ECG changes, or imaging determine whether the syndrome is MI or acute nonischemic myocardial injury.PubMed+2PubMedHigh-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. - AbstractPubMedAcute ST-Segment Elevation Myocardial Infarction (STEMI) - NCBIPubMedUse of high‐sensitivity cardiac troponin in the emergency department: A policy resource and education paper (PREP) from the American College of Emergency Physicians

Use a validated hs-cTn clinical decision pathway to assign patients to rule-out, observation, or rule-in categories.PubMed+1PubMed2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency DepartmentPubMedEffectiveness of rapid rule-out strategy for acute coronary syndrome in the emergency department: a real-world retrospective study in Asia Common accelerated approaches include 0/1-hour and 0/2-hour serial testing; their cutoffs and deltas are assay-specific and must be taken from the institution's validated protocol.PubMed+2PubMedEffectiveness of rapid rule-out strategy for acute coronary syndrome in the emergency department: a real-world retrospective study in AsiaPubMedSIRM/SIC consensus document on the management of patients with acute chest painPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review A 0/2-hour strategy may be more operationally achievable when laboratories cannot reliably return a 1-hour specimen within the required timeframe.PubMedPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

A single-draw rule-out strategy is restricted to patients meeting the pathway's conditions: a very low hs-cTn value at or near the assay limit of detection, a nonischemic ECG, and symptoms beginning more than 2 hours before blood collection.PubMed+1PubMedHigh-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation - PMCPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review Do not use a lone value below the 99th-percentile URL to rule out MI in early presenters; a single measurement at that threshold lacks the sensitivity required for safe exclusion.PubMed+1PubMedRapid rule-out of acute myocardial infarction using the 0/1-hour algorithm for cardiac troponins in emergency primary care: the OUT-ACS implementation studyPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

Patients meeting rule-out criteria through an hs-cTn pathway and having a nonischemic initial ECG may be discharged without further testing and without mandatory application of a risk score.PubMedPubMed2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department This recommendation applies to patients appropriately evaluated by the pathway; persistent or recurrent concerning symptoms, ischemic ECG evolution, or failure to meet pathway timing criteria warrants continued observation and serial assessment.PubMed+1PubMed2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency DepartmentPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

Do not use the magnitude of a single hs-cTn elevation alone to identify MI. A value above the 99th-percentile URL indicates injury, while acute MI requires a dynamic pattern and evidence of ischemia.PubMed+2PubMedHigh-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. - AbstractPubMedAcute ST-Segment Elevation Myocardial Infarction (STEMI) - NCBIPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review Conversely, a detectable hs-cTn below the URL should not be called abnormal unless it exceeds the pathway's specific threshold or demonstrates a clinically significant delta under that assay's protocol.PubMed+1PubMedUse of high‐sensitivity cardiac troponin in the emergency department: A policy resource and education paper (PREP) from the American College of Emergency PhysiciansPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

Do not compare absolute concentrations across assays. hs-cTnI and hs-cTnT assays use different calibrations, analytic limits, and 99th-percentile URLs; even two assays measuring the same troponin subtype may have noninterchangeable values.PubMedPubMedUse of high‐sensitivity cardiac troponin in the emergency department: A policy resource and education paper (PREP) from the American College of Emergency Physicians If an institution changes assays, establish a new protocol-specific baseline and avoid interpreting apparent numerical changes as biologic deltas without assay continuity.PubMedPubMedUse of high‐sensitivity cardiac troponin in the emergency department: A policy resource and education paper (PREP) from the American College of Emergency Physicians

Do not prematurely dismiss ACS because the presentation is not described as classic chest pain. In adults older than 75 years, a fall, syncope, or acute delirium may represent ACS and should prompt the same ECG-plus-hs-cTn evaluation when the clinical context is concerning.PubMedPubMedThe 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain: An Interventionalist’s Viewpoint Women have a higher prevalence of nonobstructive CAD and may have ischemic syndromes not captured by an obstructive-CAD framework alone.ScienceDirect+1ScienceDirectChest Pain in Women: Considerations From the 2021 AHA/ACC Chest Pain GuidelinePubMedThe 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain: An Interventionalist’s Viewpoint

For every serial hs-cTn evaluation, document the assay name, collection times, numeric values with units, assay-specific 99th-percentile URL, applicable delta criterion, ECG interpretation, symptom-onset timing, and resulting pathway category. This makes explicit whether the conclusion is rule-out, observation, acute myocardial injury, or acute MI and prevents later reinterpretation of an isolated value outside its protocol context.PubMed+3PubMedHigh-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain. - AbstractPubMed2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency DepartmentPubMedUse of high‐sensitivity cardiac troponin in the emergency department: A policy resource and education paper (PREP) from the American College of Emergency PhysiciansPubMedOptimizing the Clinical Use of High-Sensitivity Troponin Assays: A Review

At discharge after a completed rule-out pathway, state that MI was ruled out by the local hs-cTn clinical decision pathway in the setting of a nonischemic ECG, rather than stating that all cardiac causes were excluded.PubMedPubMed2022 ACC Expert Consensus Decision Pathway on the Evaluation and Disposition of Acute Chest Pain in the Emergency Department Persistent, recurrent, or chronic symptoms may require outpatient evaluation for stable ischemic heart disease or ischemia with no obstructive coronary arteries; a negative conventional stress test does not necessarily exclude an occult coronary cause in the latter syndrome.PubMedPubMedThe 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain: An Interventionalist’s Viewpoint